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Article focus
  The stimulation of inducible nitric oxide syn-
thase (iNoS) immediately post-osteotomy.
  The comparison of tadalafil and a nutra-
ceutical in fracture healing.
Key messages
  The upregulation of iNoS may enhance 
fracture healing as evidenced by biome-
chanical properties.
  The use of nutraceuticals that upregulate 
iNoS may be considered as a supplement 
to early fracture healing.
Strengths and limitations
  The randomised design with comparative 
control group.
  The no dose response with either treat-
ment arm.
  It was a small animal fracture model.
  The osteotomy created in metaphyseal-
diaphyseal junction.
Introduction
Fracture healing results from a complex and 
sequential cascade of cellular events that 
restore bone to its pre-fracture condition. The 
enhancement of fracture healing in 
the rat, modulated by compounds that 
stimulate inducible nitric oxide synthase
acceleraTIoN oF FracTure healINg vIa INducIble NITrIc oxIde 
SyNThaSe
Objectives
We investigated the effects on fracture healing of two up-regulators of inducible nitric oxide 
synthase (inos) in a rat model of an open femoral osteotomy: tadalafil, a phosphodiesterase 
inhibitor, and the recently reported nutraceutical, coMB-4 (consisting of L-citrulline, paullinia 
cupana, ginger and muira puama), given orally for either 14 or 42 days.
Materials and Methods
Unilateral femoral osteotomies were created in 58 male rats and fixed with an intra-
medullary compression nail. Rats were treated daily either with vehicle, tadalafil or coMB-4. 
Biomechanical testing of the healed fracture was performed on day 42. The volume, min-
eral content and bone density of the callus were measured by quantitative cT on days 14 
and 42. expression of inos was measured by immunohistochemistry.
Results
When compared with the control group, the coMB-4 group exhibited 46% higher maximum 
strength (t-test, p = 0.029) and 92% higher stiffness (t-test, p = 0.023), but no significant 
changes were observed in the tadalafil group. At days 14 and 42, there was no significant 
difference between the three groups with respect to callus volume, mineral content and 
bone density. expression of inos at day 14 was significantly higher in the coMB-4 group 
which, as expected, had returned to baseline levels at day 42.
Conclusion
This study demonstrates an enhancement in fracture healing by an oral natural product 
known to augment inos expression.
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fracture site fills with a haematoma that is rich in mesen-
chymal cells and cytokines. This represents the inflamma-
tory phase, and it is eventually followed by a reparative 
phase in which soft callus is laid down, followed by a 
remodeling phase.1 although the exact regulatory mecha-
nisms for these phases are yet to be fully understood, neo-
vascularity, as well as osteoblast recruitment at the callus 
site, appears to play a key role for successful healing.2,3
Neovascularity and osteoblastic recruitment are 
known effects of nitric oxide (No), which appears to be 
involved in the fracture healing process.4,5 No is pro-
duced by one of three isoforms of nitric oxide synthase 
(NoS) depending on tissue location and physiological 
function.6,7 While all three of these NoS isoforms are 
involved in the fracture healing process,8-10 inducible 
NoS (iNoS) appears to be the primary isoform involved 
in the stimulation of osteoblasts by No.11,12 Furthermore, 
when the iNoS gene is selectively deleted, fracture heal-
ing is impaired. This can be reversed by treatment with 
the iNoS gene.13
The effects of No are normally mediated via its 
second messenger, cyclic guanosine monophosphate 
(cgMP),14,15 which is regulated by intracellular phospho-
diesterase (Pde).16 Inhibitors of Pde, such as tadalafil, are 
known to increase intracellular cgMP and have been 
shown to accelerate early fracture healing in mice.17,18 
recently, Ferrini et al19 reported that a combination of the 
four herbal compounds, l-citrulline, ginger, Paullinia 
cupana, and muira puama (coMb-4), originally con-
ceived as an anti-fibrotic compound, appeared in an in 
vivo study to produce a marked stimulation of the iNoS 
enzyme in rats.
We hypothesise that coMb-4 is capable of stimulating 
iNoS to produce elevated levels of No and, therefore, 
will accelerate fracture healing, as has been shown with 
Pde5 inhibition.17,18 rodents have been increasingly used 
to study fracture healing due to their ease of handling 
and cost. although there is no standard model for study-
ing fracture healing in a rat, there are various fixation 
techniques and fracture models described in the litera-
ture.20 by creating a reproducible osteotomy of the femur 
and using an intramedullary (IM) nail that controlled 
both axial and rotational stability, we created a unique 
standardised experimental fracture healing model for a 
rat from which to study the effects of both tadalafil and 
coMb-4. The primary outcomes included the biome-
chanical parameters of torsional strength, stiffness, and 
fracture healing stages. Secondary outcomes were bone 
mineral density, callus volume, and iNoS expression at 
the fracture site.
Materials and Methods
experimental animals and surgical procedure. a total of 
58 male Sprague-dawley rats (ten weeks old, average body 
weight: 344 g) were obtained from harlan labs/envigo 
(Indianapolis, Indiana). The protocol #1-1403-279 was 
approved by the charles r. drew university Institutional 
animal care and use committee. Male rats were used in 
order to avoid the effects of the oestrous cycle (oestrogen) 
as a variable. The rats were housed for one week prior 
to experimental procedures to permit acclimatisation, 
and then randomly assigned to three groups. The con-
trol group (n = 19) received 0.2 ml of vehicle composed 
of 10% dimethyl sulfoxide, peanut butter and water by 
retrolingual administration. The tadalafil group (n = 20) 
received 2.0 mg/kg body weight (bW) of the Pde5 inhibi-
tor, tadalafil (eli lilly, Indianapolis, Indiana), mixed with 
the vehicle. This dose has been shown to be equivalent to 
a 20 mg/day daily dose in humans.21 The coMb-4 group 
(n = 19) received a combination of the following: muira 
puama (45 mg/kg bW), Paullinia cupana (45 mg/kg bW), 
and ginger (45 mg/kg bW) which were obtained from 
Naturex (hackensack, New Jersey) as well as l-citrulline 
(133 mg/kg bW) which was obtained from Sigma aldrich 
(St louis, Missouri). all four components were dissolved 
in the vehicle. The appropriate dose of each of the four 
components of coMb-4 for a rat was calculated based 
on the equivalent recommended human daily dose as 
previously reported.19 all animals received the vehicle 
once a day for the three days prior to surgery to adapt to 
the taste, and began receiving on a daily basis either their 
respectively assigned control, or tadalafil or coMb-4 
post osteotomy (day 0), which was continued until the 
rats were killed at two or four weeks. all surgeries were 
performed by one of the authors (aK) who was blinded 
to the rats’ experimental assignment. anaesthesia was 
induced with 3% isoflurane and maintained with 2.5% 
isoflurane throughout the surgery. all rats received sub-
cutaneous injections of buprenorphine 0.05 mg/kg bW 
for pre- and post-operative pain control.
each rat then underwent a unilateral femoral osteot-
omy with internal fixation. briefly, after shaving the skin, 
the rat was placed in the supine position and a longitudi-
nal incision 1.5 cm long-centred over the superior patella 
was made just medial to the midline. The underlying fas-
cia was incised at the medial patellar tendon border and 
the patella was dislocated laterally. The trochlea was 
opened with a 1.0 mm drill bit and the IM canal and 
greater trochanter were reamed with a 21-gauge hypo-
dermic needle. The canal was sequentially reamed with 
an 18-gauge needle, and the epicondyle was further 
opened with a 16-gauge needle. The femoral shaft was 
accessed by sweeping the vastus medialis laterally. cat 
claw scissors (Petco, San diego, california) placed at the 
distal one-third of the femoral shaft were used to make a 
transverse osteotomy. a randomiser table was used to 
determine laterality of the osteotomy. While maintaining 
control of both osteotomy fragments, a titanium com-
pression IM nail (rISystem, davos, Switzerland) was 
applied in a retrograde manner, while visualising the 
fracture reduction (Fig. 1). The use of this type of IM 
device in rodents has been previously described.17,18  
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a small amount of compression was seen at the osteot-
omy site indicating the IM nail obtained fixation proxi-
mally at the greater trochanter and the site was tested 
manually for any movement.
The fascia and skin were closed in two layers using 4-0 
vicryl (ethicon Inc., Somerville, New Jersey) and vetbond 
skin glue (3M, St. Paul, Minnesota). a small amount of 
triple antibiotic ointment (actavis, Parsippany, New 
Jersey) was applied to the skin. range of movement at 
the hip and knee was performed to ensure there was no 
penetration of the IM nail proximally and that the patella 
tracked appropriately. unprotected weight-bearing was 
permitted immediately post-operatively, and on day 14, 
five rats from each of the three groups were killed using 
inhalational co2 and the femurs were harvested for 
quantitative cT (qcT) and histological evaluation. on 
day 42, five rats from each group were killed for the qcT 
and histological evaluation. The remaining 28 rats were 
killed for biomechanical testing.
Callus development analysis via qCT – mineral content 
and callus volume. a quantitative determination of callus 
development at days 14 and 42 was obtained with a qcT 
(xcT 3000, Stratec, Pforzheim, germany). This method 
was selected because it allows 3d, quantitative evalua-
tion of fracture healing, including callus development at 
the fracture site. Parameters were quantified as the cross-
sectional transverse area, bone mineral content and 
bone density.
after removal of the IM nail, a bony section 3 mm in 
length, that included the osteotomy site in the centre, 
was analysed using three consecutive transverse qcT 
scans of 1.1 mm in thickness and 0.1 mm × 0.1 mm in 
pixel size. a total of three images were obtained; one for 
the bone fragment proximal to the osteotomy, one for 
the osteotomy site itself and one for the distal bone frag-
ment. xcT Series software package (version 5.21, Stratec) 
was used to calculate the mineral content, mineralised 
callus area and bone mineral density of each image. Total 
mineral content and callus volume of the 3 mm segment 
was calculated by combining all three section values. In 
order to assess progression of remodeling, higher density 
callus (> 500 mg/cm3) was measured and separated from 
total callus (> 299 mg/cm3). Mineral density greater than 
850 mg/cm3 was considered cortical bone density and 
was eliminated from newly formed callus calculations.22
Biomechanical evaluation. after euthanasia at day 42, 
each femur was harvested and both ends of the femur 
were embedded in blocks of polymethylmethacrylate 
after removal of the IM nail. only a 12 mm long seg-
ment of the bone, which included the osteotomy in the 
centre, was exposed. The specimen was then secured 
onto a torsional testing apparatus mounted into an MTS 
bi-axial load frame (MTS mini-bionix 858, Minneapolis, 
Minnesota). Torsion to failure was applied at a rate of 
12°/min.23 There were two parameters derived from the 
torque-displacement curve for each specimen’s load 
to failure test: torsional stiffness and maximum torque. 
additionally, using the failure pattern, each specimen was 
classified into one of four biomechanical stages of frac-
ture repair as described by White et al.24 a Stage I fracture 
is rubbery, indicating only soft callus formation. Stages 
II through Iv exhibit higher stiffness, indicating failure of 
bone with progressively higher mineralised tissue. Stage 
I and II fractures fail through the original osteotomy line. 
Stage III failure occurred partially through the original 
osteotomy line and partially through intact bone, while 
Stage Iv failure occurred entirely through intact bone.
Immunohistochemical expression of iNOS. after fixa-
tion in 4% p-formaldehyde, femurs from both days 
14 and 42 were decalcified in 10% formic acid for five 
days. each femur was rinsed in PbS, both epiphyses 
were removed and the shaft was cut longitudinally in 
two halves. both halves were processed for paraffin 
embedding sections. Five-micrometer paraffin embed-
ded sections were employed for immunostaining with 
polyclonal antibody (dilution 1:250) against iNoS (bd 
Pharmingen, San diego, california). Next, the sections 
were then incubated with biotinylated anti-rabbit 
Igg, respectively, followed by abc complex (vector 
labs, Temecula, california) and 3,3’diaminobenzidine 
(Sigma aldrich) slides were counter-stained with a 
Fig. 1
representative radiograph of a femur fixed with the intramedullary (IM) nail. 
The proximal end of the IM nail has a thread that permits compression of the 
femur fragments. This radiograph was taken after harvest at day 14.
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hematoxylin solution. Stained sections were dehydrated 
and then mounted with Permount. at least six pictures 
per section were taken with a leica microscope (leica 
Microsystems, Wetzlar, germany) at 200× magnifica-
tion. Integrated optical density (Iod) per cell was deter-
mined using Image Pro 7.1 software (Media cybernetics, 
Silver Spring, Maryland). after images were calibrated 
for background lighting, Iod results are proportional 
to the unweighted average optical density, which is 
used to determine the concentration of immunoreac-
tive antigen. each slide assayed had its corresponding 
negative control. In all cases, six non-overlapping fields 
were screened per tissue sections and at least three 
sections per animal were analysed.
Statistical analysis. a one-way analysis of variance 
(aNova) was used to compare the outcome variables, 
including callus volume, bone mineral content, bone 
density, torsional stiffness and maximum torque at fail-
ure. The independent variables were days 14 and 42 and 
treatment type (three categories including control). one-
way aNova was followed by least significant difference 
post hoc tests to compare individual pairs of groups. Non-
parametric tests were used to compare the fracture repair 
stages among the three groups.
Fig. 2
representative quantitative cT (qcT) images of the three groups at days 14 and 42. These qcT images were taken 1 mm below the osteotomy site to eliminate 
bone fragment overlap at the osteotomy level. The right side bar indicates bone mineral density.
Table I. Newly formed total and hard callus at the osteotomy site at days 14 and 42 (presented as mean and standard error of the mean)
Callus volume (mm3) Mineral content (mg) Bone density (mg/cm3)
Group Day 14 Day 42 Day 14 Day 42 Day 14 Day 42
Newly formed total callus (> 299 mg/cm3)
control 44.0 (4.5) 64.0 (9.0) 19.7 (2.4) 33.0 (5.1) 445.8 (11.6) 512.2 (8.1)
Tadalafil 44.9 (5.8) 66.3 (10.1) 20.8 (3.2) 34.1 (5.7) 458.4 (14.6) 510.0 (8.5)
coMb-4 37.3 (3.9) 63.2 (4.8) 16.4 (1.9) 31.7 (2.8) 438.4 (4.5) 500.0 (8.9)
Newly formed hard callus (> 500 mg/cm3)
control 15.1 (2.2) 35.7 (5.5) 10.0 (1.4) 24.6 (3.6) 659 (4.7) 693.2 (11.9)
Tadalafil 16.4 (2.4) 35.6 (5.6) 11.0 (1.6) 24.1 (3.7) 665 (1.0) 697.2 (5.5)
coMb-4 13.3 (1.4) 33.4 (3.5) 8.8 (0.9) 22.8 (2.4) 661 (4.4) 683.7 (2.5)
n = 4 for day 14 control and tadalafil, and day 42 coMb-4 groups; n = 5 for day 14 coMb-4 and day 42 control and tadalafil groups
COMB-4: L-citrulline, Paullinia cupana, ginger and muira puama
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For quantitative image analysis of the histological 
observations, values were expressed as the mean and 
standard error of the mean (sem). The normality distribu-
tion of the data was established using the Wilk-Shapiro 
test. Multiple comparisons were analysed by a single 
factor analysis of variance, followed by post hoc 
comparisons with the Tukey test according to graphPad 
Prism (version 5.1) for Windows (graphPad Software, 
San diego, california). a p-value of < 0.05 was consid-
ered significant.
Results
a total of five rats (two from day 14 and three from day 
42) were excluded from the study due to either an infec-
tion discovered at the osteotomy site (n = 4) or a com-
minuted fracture (n = 1). Therefore, only 53 animals were 
used for the analysis.
Callus development analysis – mineral content and callus 
volume. all three groups demonstrated about a 50% 
increase in both the mineral content and mineralised 
callus volume at the osteotomy site at day 42 when 
compared with day 14 (Table I). however, at both of 
these time points neither the tadalafil nor the coMb-4 
group demonstrated a statistically significant differ-
ence compared with the control group. representative 
qcT images of the three experimental groups at the 
two different time points are shown in Figure 2.
Biomechanical properties. at day 42, the mean val-
ues for all three biomechanical parameters (maximum 
torque, torsional stiffness and fracture repair stage) 
were highest in the coMb-4 group (Table II, Fig. 3). 
The coMb-4 group exhibited 46% higher maximum 
strength (p = 0.029) and 92% higher stiffness (p = 0.023) 
than those of the control group. The coMb-4 group also 
exhibited 29% higher maximum strength (p = 0.497) and 
50% higher stiffness (p = 0.396) than that of the tadalfil 
group but this difference was not statistically significant. 
The tadalafil group exhibited 15% higher maximum 
strength (p = 0.125) and 28% higher stiffness (p = 0.076) 
with respect to the control group, but this change was 
not statistically significant.
all of the osteotomies were healed at day 42 and 
were higher than Stage II of the biomechanical classifica-
tion of fracture repair. Stage Iv fracture repairs were not 
seen in the tadalafil or in the control groups, but were 
seen in four rats from the coMb-4 treatment group. 
Table II. biomechanical properties of healed fractures at day 42 (from torsion test, presented as mean and standard error of the mean)
Group Fracture repair stage (I, II, III or IV)† Maximum torque (Nmm) Torsional stiffness (Nmm/°)
control (n = 7) 2.4 (0.2) II n = 4; III n = 3; Iv n = 0 283.3 (59.8) 46.8 (12.8)
Tadalafil (n = 10) 2.4 (0.2) II n = 6; III n = 4; Iv n = 0 326.8 (50.0) 59.9 (10.7)
coMb-4 (n = 9) 2.8 (0.3) II n = 3; III n = 2; Iv n = 4 421.3 (52.0)* p = 0.029 89.9 (11.24)* p = 0.023
*compared with control using analysis of variance followed by least significant difference for multiple comparisons
†fracture repair stage numerical conversion for mean and standard error of the mean
COMB-4: L-citrulline, Paullinia cupana, ginger and muira puama
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Fig. 3
Maximum torque (strength) and stiffness of healing fracture at day 42. results 
are expressed as mean and standard error of the mean (* p < 0.05 when com-
pared with control group using analysis of variance followed by least signifi-
cant difference for multiple comparisons).
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Fig. 4
graph showing the effect of tadalafl and coMb-4 on inducible nitric oxide 
synthase (iNoS) expression at day 14 and day 42 after femoral osteotomy. The 
graph shows quatitative image analysis results of the intensity of iNoS expres-
sion per cell. results are expressed as mean and standard error of the mean 
(* p = 0.043; ** p = 0.002 when compared with control group, using analysis 
of variance followed by Tukey as post hoc test) (coMb-4: l-citrulline, Paullinia 
cupana, ginger and muira puama).
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The remaining factures in the three groups were either 
Stage II or Stage III ( Table II ). 
 Immunohistochemical expression of iNOS .  at 14 days after 
the osteotomy, iNoS expression measured at the callus 
level was significantly increased in the tadalafil group 
by 30% (9.45  sem 1.08, p  = 0.043) and in the coMb-4 
group by 180% (18.43  sem 4.34, p  = 0.002) when com-
pared with the control group (6.38  sem 1.06) ( Fig. 4 ). 
expression of iNoS was localised mostly in chondrocytes 
at the level of the cartilaginous callus and in osteoblasts 
at the calcification front ( Figs 5a ,  5c and  5f ). however, as 
expected, iNoS expression in all three groups at day 42 
had returned to baseline values ( Figs 5b ,  5d and  5f ). 
 Discussion 
 This study was conceived to determine whether pro-
longed upregulation of the No-cgMP pathway via iNoS 
immediately following a fracture would enhance the 
healing process. This hypothesis came about from the 
observation that No is involved in fracture healing as 
shown by the induction of all three isoforms of NoS in a 
specific sequential manner during the fracture healing 
process;  8 - 10 , 25  iNoS is known to be expressed in different 
tissues in response to an injury  26 , 27  and its induction in 
such injured tissues is considered a protective mecha-
nism against abnormal wound healing;  28  iNoS is the first 
NoS isoform induced immediately and rapidly following 
 
 effect of tadalafil and coMb-4 on inducible nitric oxide synthase (iNoS) expression at day 14 and day 42 after femoral osteotomy determined by immunohisto-
chemistry. Microphotographs of iNoS expression taken at the osteotomy site: a) and b) are control; c) and d) are tadalafil; e) and f) are coMb-4. Panels (a), (c) 
and (e) depict 14-day results and panels (b), (d) and (f) depict 42-day results. 
Fig. 5a Fig. 5b
Fig. 5c
Fig. 5e Fig. 5f
Fig. 5d
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a fracture but then tapers off after peaking around the 
one- to two-week mark;8-10 and iNoS is closely involved 
with osteoblast function and bone formation.11,29 
Furthermore, although inhibition of all three NoS genes 
will result in retardation of both bone formation and nor-
mal fracture healing,9,30 it has been shown that the spe-
cific targeted inhibition or deletion of the iNoS enzyme 
will negatively impact the fracture healing process while 
replacement of the deficient iNoS gene to iNoS deficient 
animals will result in normal fracture healing.13
Pde inhibitors are compounds that can upregulate 
iNoS via the No-cgMP pathway31 and have been 
reported to enhance fracture healing17 as well as pro-
mote the differentiation of osteogenic precursor cells to 
osteoblasts.32 however, after 42 days of daily tadalafil, 
fracture healing, as measured by either the biomechani-
cal fracture repair stage, maximum torque or torsional 
stiffness, was not significantly enhanced when compared 
with the control condition.
In contrast, coMb-4, a product consisting of a pre-
determined mixture of the four natural constituents of 
l-citrulline, ginger, muira puama and Paullinia cupana, 
recently reported as an up-regulator of iNoS,19 significantly 
enhanced fracture healing as measured by biomechanical 
properties. In the present study, the smaller mineralised 
callus volume and the newly mineralised callus seen in 
these coMb-4 animals may be indicative of an accelerated 
mineralisation of bridging callus that contributes to the 
superior biomechanical properties of the coMb-4 group 
compared with both the tadalafil and control groups.
It is possible that the biomechanical findings of the 
tadalafil group could be attributed to the dosage of tada-
lafil used. The 2 mg/kg daily dosage of tadalafil used in 
this study was lower than the 5 mg/kg dose reported 
in the literature to be efficacious as an anti-fibrotic agent 
in the rat.33 This 5 mg/kg dose in the rat is equivalent to 
40 mg per day in a human,21 which supersedes the high-
est human recommended daily dose for this drug when 
administered for urological dysfunctions,34 but is consid-
ered to be an optimum dose for patients with pulmonary 
arterial hypertension.35 We speculate that the difference 
in effect between tadalafil and coMb-4 could be attrib-
uted to the varying dosages of tadalafil used in the above-
mentioned studies as well as to absorption of the tadalafil. 
Some of those studies used non-soluble media with 
ingestion of the product while others used a dissolvable 
solution with a differential effect of the product on stimu-
lating iNoS.
our study in the rat has several limitations. First, we 
used an unlocked IM nailing system and, as such, axial 
and rotational stability was not fully controlled. This may 
have led to some displacement of a fracture fragment 
due to a larger medullary canal at the distal diaphysis, 
where most of the osteotomies were located, such that 
the reduction may not have been perfect and resulted in 
different patterns of callus formation.22,36 It is also known 
that fracture callus development and size are affected by 
the stability of the fracture.37 Finally, as stated earlier, the 
dosages of tadalafil and coMb-4 were individually calcu-
lated based on previous published studies in the rat and 
prescribed human dosages. It is possible that these doses 
were not optimum for treating a fracture in this animal 
model because of potential pharmacokinetic differences 
between the human and the rat. Further investigation 
using different doses of both tadalafil and coMb-4, sin-
gly or in combination, may be required to elucidate the 
optimum dose of each product.
This study demonstrates the efficacy of a natural prod-
uct in enhancing the functional strength of bone follow-
ing an osteotomy in a rat. coMb-4 by itself resulted in 
excellent biomechanical properties associated with frac-
ture healing when compared with that seen with either 
the control or tadalafil group. l-citrulline, muira puama, 
Paullinia cupana and ginger, the constituents of coMb-
4, are known in humans to have an innocuous side effect 
profile.38,39 It is possible that coMb-4 may play a poten-
tial future role in enhancing the healing process associ-
ated with musculoskeletal fractures, although additional 
studies will certainly be required in humans to confirm its 
clinical efficacy.
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